Jason et al. reported that ADP-ribosylation factor 1 (ARF1), a crucial regulator in vesicle-mediated membrane trafficking and involved in the activation of signaling molecules, promotes the occurrence of prostate cancer via targeting oncogenic MAPK signaling (Davis et al., 2016). This evidence concerns the gene ARF1 and Familial prostate cancer.